SCHEMBL1973833

SCHEMBL1973833

O=C(Nc1nc2ccccc2[nH]1)c1ccc2[nH]c(Nc3c(Cl)cccc3Cl)nc2c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 13/20 0.66
RAB9A P51151 12/20 0.66
KMT2A Q03164 6/20 0.66
MEN1 O00255 5/20 0.66
SMN1; SMN2 Q16637 5/20 0.61
MAPT P10636 2/20 0.61
MCL1 Q07820 1/20 0.61
PKM P14618 4/20 0.58
MAOB P27338 1/20 0.58
ADORA2A P29274 1/20 0.58
IRAK4 Q9NWZ3 1/20 0.57
TP53 P04637 2/20 0.57
SCD O00767 1/20 0.57
OPRK1 P41145 1/20 0.57
KLF5 Q13887 1/20 0.57
KDM4E B2RXH2 1/20 0.57
HSD17B10 Q99714 1/20 0.57
ALDH1A1 P00352 1/20 0.57
HTT P42858 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1963984 0.89 PTGES (0.52) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL16364384 0.89 NPC1 (0.54) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL1973147 0.88 IRAK4 (0.58) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL13393490 0.87 NPC1 (0.51) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL16364382 0.86 NPC1 (0.47) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL16364380 0.86 NPC1 (0.50) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL1975926 0.86 NPC1 (0.47) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL13393449 0.85 MAPT (0.50) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL1966375 0.85 LCK (0.49) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL1970280 0.85 MAOB (0.54) NPC1RAB9AKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2334652-A1 1H-BENZ IMIDAZOLE-5-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS Boehringer Ingelheim International GmbH (DE) 2011-06-22 EP claimed
US-8916599-B2 1H-benz imidazole-5-carboxamides as anti-inflammatory agents OREXO AB (SE) 2014-12-23 US disclosed
US-20110312935-A1 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312935-A1 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents MAPRE2, MAPRE1, H1-4 NPC1 4650/4885RAB9A 867/4885KMT2A 1047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.